PubMed:32026671 / 0-301 JSONTXT

{"project":"LitCovid-PAS-Enju","denotations":[{"id":"EnjuParser_T0","span":{"begin":0,"end":1},"obj":"-LRB-"},{"id":"EnjuParser_T1","span":{"begin":1,"end":9},"obj":"NN"},{"id":"EnjuParser_T2","span":{"begin":10,"end":12},"obj":"IN"},{"id":"EnjuParser_T3","span":{"begin":13,"end":21},"obj":"JJ"},{"id":"EnjuParser_T4","span":{"begin":22,"end":30},"obj":"NNS"},{"id":"EnjuParser_T5","span":{"begin":31,"end":33},"obj":"IN"},{"id":"EnjuParser_T6","span":{"begin":34,"end":36},"obj":"CD"},{"id":"EnjuParser_T7","span":{"begin":37,"end":45},"obj":"NNS"},{"id":"EnjuParser_T8","span":{"begin":46,"end":50},"obj":"IN"},{"id":"EnjuParser_T9","span":{"begin":51,"end":55},"obj":"CD"},{"id":"EnjuParser_T10","span":{"begin":56,"end":61},"obj":"JJ"},{"id":"EnjuParser_T11","span":{"begin":62,"end":73},"obj":"NN"},{"id":"EnjuParser_T12","span":{"begin":74,"end":83},"obj":"NN"},{"id":"EnjuParser_T13","span":{"begin":83,"end":84},"obj":"-RRB-"},{"id":"EnjuParser_T14","span":{"begin":86,"end":95},"obj":"NN"},{"id":"EnjuParser_T15","span":{"begin":95,"end":96},"obj":"-COLON-"},{"id":"EnjuParser_T16","span":{"begin":97,"end":99},"obj":"TO"},{"id":"EnjuParser_T17","span":{"begin":100,"end":107},"obj":"VB"},{"id":"EnjuParser_T18","span":{"begin":108,"end":111},"obj":"DT"},{"id":"EnjuParser_T19","span":{"begin":112,"end":120},"obj":"JJ"},{"id":"EnjuParser_T20","span":{"begin":121,"end":136},"obj":"NNS"},{"id":"EnjuParser_T21","span":{"begin":137,"end":139},"obj":"IN"},{"id":"EnjuParser_T22","span":{"begin":140,"end":144},"obj":"CD"},{"id":"EnjuParser_T23","span":{"begin":145,"end":150},"obj":"JJ"},{"id":"EnjuParser_T24","span":{"begin":151,"end":162},"obj":"NN"},{"id":"EnjuParser_T25","span":{"begin":163,"end":164},"obj":"-LRB-"},{"id":"EnjuParser_T26","span":{"begin":164,"end":173},"obj":"NN"},{"id":"EnjuParser_T27","span":{"begin":173,"end":174},"obj":"-RRB-"},{"id":"EnjuParser_T28","span":{"begin":175,"end":184},"obj":"NN"},{"id":"EnjuParser_T29","span":{"begin":185,"end":188},"obj":"CC"},{"id":"EnjuParser_T30","span":{"begin":189,"end":191},"obj":"TO"},{"id":"EnjuParser_T31","span":{"begin":192,"end":203},"obj":"VB"},{"id":"EnjuParser_T32","span":{"begin":204,"end":207},"obj":"DT"},{"id":"EnjuParser_T33","span":{"begin":208,"end":219},"obj":"NN"},{"id":"EnjuParser_T34","span":{"begin":220,"end":227},"obj":"IN"},{"id":"EnjuParser_T35","span":{"begin":228,"end":233},"obj":"NN"},{"id":"EnjuParser_T36","span":{"begin":234,"end":246},"obj":"JJ"},{"id":"EnjuParser_T37","span":{"begin":247,"end":256},"obj":"NNS"},{"id":"EnjuParser_T38","span":{"begin":257,"end":260},"obj":"CC"},{"id":"EnjuParser_T39","span":{"begin":261,"end":269},"obj":"NN"},{"id":"EnjuParser_T40","span":{"begin":270,"end":272},"obj":"IN"},{"id":"EnjuParser_T41","span":{"begin":273,"end":276},"obj":"DT"},{"id":"EnjuParser_T42","span":{"begin":277,"end":284},"obj":"NN"},{"id":"EnjuParser_T43","span":{"begin":286,"end":293},"obj":"NNS"},{"id":"EnjuParser_T44","span":{"begin":293,"end":294},"obj":"-COLON-"},{"id":"EnjuParser_T45","span":{"begin":295,"end":297},"obj":"CD"}],"relations":[{"id":"EnjuParser_R0","pred":"arg1Of","subj":"EnjuParser_T1","obj":"EnjuParser_T0"},{"id":"EnjuParser_R1","pred":"arg1Of","subj":"EnjuParser_T1","obj":"EnjuParser_T2"},{"id":"EnjuParser_R2","pred":"arg2Of","subj":"EnjuParser_T4","obj":"EnjuParser_T2"},{"id":"EnjuParser_R3","pred":"arg1Of","subj":"EnjuParser_T4","obj":"EnjuParser_T3"},{"id":"EnjuParser_R4","pred":"arg1Of","subj":"EnjuParser_T4","obj":"EnjuParser_T5"},{"id":"EnjuParser_R5","pred":"arg2Of","subj":"EnjuParser_T7","obj":"EnjuParser_T5"},{"id":"EnjuParser_R6","pred":"arg1Of","subj":"EnjuParser_T7","obj":"EnjuParser_T6"},{"id":"EnjuParser_R7","pred":"arg1Of","subj":"EnjuParser_T7","obj":"EnjuParser_T8"},{"id":"EnjuParser_R8","pred":"arg2Of","subj":"EnjuParser_T12","obj":"EnjuParser_T8"},{"id":"EnjuParser_R9","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T9"},{"id":"EnjuParser_R10","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T10"},{"id":"EnjuParser_R11","pred":"arg1Of","subj":"EnjuParser_T12","obj":"EnjuParser_T11"},{"id":"EnjuParser_R12","pred":"arg1Of","subj":"EnjuParser_T1","obj":"EnjuParser_T13"},{"id":"EnjuParser_R13","pred":"arg1Of","subj":"EnjuParser_T14","obj":"EnjuParser_T15"},{"id":"EnjuParser_R14","pred":"arg1Of","subj":"EnjuParser_T17","obj":"EnjuParser_T16"},{"id":"EnjuParser_R15","pred":"arg2Of","subj":"EnjuParser_T20","obj":"EnjuParser_T17"},{"id":"EnjuParser_R16","pred":"arg1Of","subj":"EnjuParser_T20","obj":"EnjuParser_T18"},{"id":"EnjuParser_R17","pred":"arg1Of","subj":"EnjuParser_T20","obj":"EnjuParser_T19"},{"id":"EnjuParser_R18","pred":"arg1Of","subj":"EnjuParser_T20","obj":"EnjuParser_T21"},{"id":"EnjuParser_R19","pred":"arg2Of","subj":"EnjuParser_T28","obj":"EnjuParser_T21"},{"id":"EnjuParser_R20","pred":"arg1Of","subj":"EnjuParser_T28","obj":"EnjuParser_T22"},{"id":"EnjuParser_R21","pred":"arg1Of","subj":"EnjuParser_T28","obj":"EnjuParser_T23"},{"id":"EnjuParser_R22","pred":"arg1Of","subj":"EnjuParser_T28","obj":"EnjuParser_T24"},{"id":"EnjuParser_R23","pred":"arg1Of","subj":"EnjuParser_T28","obj":"EnjuParser_T25"},{"id":"EnjuParser_R24","pred":"arg2Of","subj":"EnjuParser_T26","obj":"EnjuParser_T25"},{"id":"EnjuParser_R25","pred":"arg3Of","subj":"EnjuParser_T27","obj":"EnjuParser_T25"},{"id":"EnjuParser_R26","pred":"arg1Of","subj":"EnjuParser_T17","obj":"EnjuParser_T29"},{"id":"EnjuParser_R27","pred":"arg2Of","subj":"EnjuParser_T31","obj":"EnjuParser_T29"},{"id":"EnjuParser_R28","pred":"arg1Of","subj":"EnjuParser_T31","obj":"EnjuParser_T30"},{"id":"EnjuParser_R29","pred":"arg2Of","subj":"EnjuParser_T33","obj":"EnjuParser_T31"},{"id":"EnjuParser_R30","pred":"arg1Of","subj":"EnjuParser_T33","obj":"EnjuParser_T32"},{"id":"EnjuParser_R31","pred":"arg1Of","subj":"EnjuParser_T33","obj":"EnjuParser_T34"},{"id":"EnjuParser_R32","pred":"arg2Of","subj":"EnjuParser_T38","obj":"EnjuParser_T34"},{"id":"EnjuParser_R33","pred":"arg1Of","subj":"EnjuParser_T37","obj":"EnjuParser_T35"},{"id":"EnjuParser_R34","pred":"arg1Of","subj":"EnjuParser_T37","obj":"EnjuParser_T36"},{"id":"EnjuParser_R35","pred":"arg1Of","subj":"EnjuParser_T37","obj":"EnjuParser_T38"},{"id":"EnjuParser_R36","pred":"arg2Of","subj":"EnjuParser_T39","obj":"EnjuParser_T38"},{"id":"EnjuParser_R37","pred":"arg1Of","subj":"EnjuParser_T39","obj":"EnjuParser_T40"},{"id":"EnjuParser_R38","pred":"arg2Of","subj":"EnjuParser_T42","obj":"EnjuParser_T40"},{"id":"EnjuParser_R39","pred":"arg1Of","subj":"EnjuParser_T42","obj":"EnjuParser_T41"},{"id":"EnjuParser_R40","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T44"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-ArguminSci","denotations":[{"id":"T1","span":{"begin":0,"end":85},"obj":"DRI_Background"},{"id":"T2","span":{"begin":86,"end":285},"obj":"DRI_Background"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-OGER","denotations":[{"id":"T1","span":{"begin":228,"end":233},"obj":"UBERON:0001977"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PubTatorCentral","denotations":[{"id":"T1","span":{"begin":37,"end":45},"obj":"Species:9606"},{"id":"T2","span":{"begin":62,"end":83},"obj":"Disease:MESH:D018352"},{"id":"T3","span":{"begin":175,"end":184},"obj":"Disease:MESH:D011014"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":86,"end":96},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":97,"end":285},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":286,"end":294},"obj":"Sentence"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok1","span":{"begin":0,"end":1},"obj":"NN"},{"id":"tok2","span":{"begin":1,"end":9},"obj":"NNP"},{"id":"tok3","span":{"begin":10,"end":12},"obj":"IN"},{"id":"tok4","span":{"begin":13,"end":21},"obj":"JJ"},{"id":"tok5","span":{"begin":22,"end":30},"obj":"NNS"},{"id":"tok6","span":{"begin":31,"end":33},"obj":"IN"},{"id":"tok7","span":{"begin":34,"end":36},"obj":"CD"},{"id":"tok8","span":{"begin":37,"end":45},"obj":"NNS"},{"id":"tok9","span":{"begin":46,"end":50},"obj":"IN"},{"id":"tok10","span":{"begin":51,"end":55},"obj":"CD"},{"id":"tok11","span":{"begin":56,"end":61},"obj":"NN"},{"id":"tok12","span":{"begin":62,"end":73},"obj":"JJ"},{"id":"tok13","span":{"begin":74,"end":83},"obj":"NN"},{"id":"tok14","span":{"begin":83,"end":84},"obj":"NN"},{"id":"tok15","span":{"begin":84,"end":85},"obj":"."},{"id":"tok16","span":{"begin":86,"end":95},"obj":"NNP"},{"id":"tok17","span":{"begin":95,"end":96},"obj":":"},{"id":"tok18","span":{"begin":97,"end":99},"obj":"TO"},{"id":"tok19","span":{"begin":100,"end":107},"obj":"VB"},{"id":"tok20","span":{"begin":108,"end":111},"obj":"DT"},{"id":"tok21","span":{"begin":112,"end":120},"obj":"JJ"},{"id":"tok22","span":{"begin":121,"end":136},"obj":"NNS"},{"id":"tok23","span":{"begin":137,"end":139},"obj":"IN"},{"id":"tok24","span":{"begin":140,"end":144},"obj":"CD"},{"id":"tok25","span":{"begin":145,"end":150},"obj":"NN"},{"id":"tok26","span":{"begin":151,"end":162},"obj":"JJ"},{"id":"tok27","span":{"begin":163,"end":164},"obj":"("},{"id":"tok28","span":{"begin":164,"end":168},"obj":"CD"},{"id":"tok29","span":{"begin":168,"end":169},"obj":":"},{"id":"tok30","span":{"begin":169,"end":173},"obj":"NN"},{"id":"tok31","span":{"begin":173,"end":174},"obj":")"},{"id":"tok32","span":{"begin":175,"end":184},"obj":"NN"},{"id":"tok33","span":{"begin":185,"end":188},"obj":"CC"},{"id":"tok34","span":{"begin":189,"end":191},"obj":"TO"},{"id":"tok35","span":{"begin":192,"end":203},"obj":"VB"},{"id":"tok36","span":{"begin":204,"end":207},"obj":"DT"},{"id":"tok37","span":{"begin":208,"end":219},"obj":"NN"},{"id":"tok38","span":{"begin":220,"end":227},"obj":"IN"},{"id":"tok39","span":{"begin":228,"end":233},"obj":"NN"},{"id":"tok40","span":{"begin":234,"end":246},"obj":"JJ"},{"id":"tok41","span":{"begin":247,"end":256},"obj":"NNS"},{"id":"tok42","span":{"begin":257,"end":260},"obj":"CC"},{"id":"tok43","span":{"begin":261,"end":269},"obj":"NN"},{"id":"tok44","span":{"begin":270,"end":272},"obj":"IN"},{"id":"tok45","span":{"begin":273,"end":276},"obj":"DT"},{"id":"tok46","span":{"begin":277,"end":284},"obj":"NN"},{"id":"tok47","span":{"begin":284,"end":285},"obj":"."},{"id":"tok48","span":{"begin":286,"end":293},"obj":"NNP"},{"id":"tok49","span":{"begin":293,"end":294},"obj":":"},{"id":"tok50","span":{"begin":295,"end":297},"obj":"CD"},{"id":"lookup1","span":{"begin":51,"end":55},"obj":"year"},{"id":"lookup2","span":{"begin":140,"end":144},"obj":"year"},{"id":"lookup3","span":{"begin":164,"end":168},"obj":"year"},{"id":"lookup4","span":{"begin":189,"end":191},"obj":"country_code"},{"id":"event2","span":{"begin":192,"end":203},"obj":"I_ACTION"},{"id":"event22","span":{"begin":100,"end":107},"obj":"OCCURRENCE"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T1","span":{"begin":74,"end":83},"obj":"Disease"},{"id":"T2","span":{"begin":175,"end":184},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PD-HP-v1","denotations":[{"id":"T1","span":{"begin":74,"end":83},"obj":"Phenotype"},{"id":"T2","span":{"begin":175,"end":184},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PD-FMA-UBERON-v1","denotations":[{"id":"T1","span":{"begin":228,"end":233},"obj":"Body_part"},{"id":"T2","span":{"begin":247,"end":256},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A66270","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T2","span":{"begin":86,"end":96},"obj":"Sentence"},{"id":"T3","span":{"begin":97,"end":285},"obj":"Sentence"},{"id":"T4","span":{"begin":286,"end":294},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T2","span":{"begin":86,"end":96},"obj":"Sentence"},{"id":"T3","span":{"begin":97,"end":285},"obj":"Sentence"},{"id":"T4","span":{"begin":286,"end":294},"obj":"Sentence"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":228,"end":233},"obj":"Body_part"},{"id":"T2","span":{"begin":247,"end":256},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":228,"end":233},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":74,"end":83},"obj":"Disease"},{"id":"T2","span":{"begin":175,"end":184},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":86,"end":95},"obj":"http://purl.obolibrary.org/obo/BFO_0000030"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":74,"end":83},"obj":"Phenotype"},{"id":"T2","span":{"begin":175,"end":184},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":85},"obj":"Sentence"},{"id":"T2","span":{"begin":86,"end":96},"obj":"Sentence"},{"id":"T3","span":{"begin":97,"end":285},"obj":"Sentence"},{"id":"T4","span":{"begin":286,"end":294},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2","span":{"begin":37,"end":45},"obj":"Species"},{"id":"3","span":{"begin":56,"end":83},"obj":"Disease"},{"id":"39","span":{"begin":151,"end":184},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"tao:has_database_id","subj":"2","obj":"Tax:9606"},{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:C000657245"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].\nObjective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 pat"}